| scholarly article | Q13442814 |
| P2093 | author name string | Christopher Chang | |
| Rong Xiao | |||
| Yan Ding | |||
| Haijing Wu | |||
| Yangyang Luo | |||
| Qiancheng Deng | |||
| P2860 | cites work | Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis | Q21135220 |
| The redox state of free nicotinamide-adenine dinucleotide phosphate in the cytoplasm of rat liver | Q24534966 | ||
| The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control | Q24597971 | ||
| A diverse range of gene products are effectors of the type I interferon antiviral response | Q24626018 | ||
| Metaboloepigenetics: interrelationships between energy metabolism and epigenetic control of gene expression | Q24632160 | ||
| mTOR regulates memory CD8 T-cell differentiation | Q24648624 | ||
| Chromatin modifications and their function | Q27861067 | ||
| DNA methylation regulates MicroRNA expression | Q28238278 | ||
| Role of the microRNA-17-92 cluster in the endothelial differentiation of stem cells | Q28271151 | ||
| Protein acetylation as a means to regulate protein function in tune with metabolic state. | Q38238650 | ||
| Metabolic regulation of histone post-translational modifications. | Q38308759 | ||
| Epigenetic control of autoimmune diseases: from bench to bedside. | Q38313553 | ||
| Epigenetics and metabolism. | Q38353919 | ||
| Acetyl-CoA and the regulation of metabolism: mechanisms and consequences. | Q38363821 | ||
| Epigenetic profiling in CD4+ and CD8+ T cells from Graves' disease patients reveals changes in genes associated with T cell receptor signaling | Q38456448 | ||
| Epigenetics in autoimmune diseases: Pathogenesis and prospects for therapy | Q38508801 | ||
| Epigenetic mechanisms: An emerging role in pathogenesis and its therapeutic potential in systemic sclerosis | Q38516131 | ||
| Epigenetics changes associated to environmental triggers in autoimmunity | Q38586605 | ||
| MiR-15a/16 deficiency enhances anti-tumor immunity of glioma-infiltrating CD8+ T cells through targeting mTOR. | Q38652482 | ||
| Metabolic control of methylation and acetylation | Q38656660 | ||
| Management of Graves Disease: A Review | Q38670281 | ||
| Canonical Wnt signaling in systemic sclerosis | Q38692353 | ||
| Oxidative stress drives CD8+ T-cell skin trafficking in patients with vitiligo through CXCL16 upregulation by activating the unfolded protein response in keratinocytes. | Q38732156 | ||
| Adaptive immunity in HBV infection | Q38809554 | ||
| Roles of regulatory T cells in cancer immunity | Q38830072 | ||
| DNA Methylation: a New Player in Multiple Sclerosis | Q38851770 | ||
| The role of microRNAs in the pathogenesis of autoimmune diseases. | Q38957443 | ||
| DNA demethylation pathways: Additional players and regulators | Q39012256 | ||
| Epigenetic modifications and epigenetic based medication implementations of autoimmune diseases | Q39021819 | ||
| Altered expression of miR-17-5p in CD4+ lymphocytes of relapsing-remitting multiple sclerosis patients | Q28272970 | ||
| Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging | Q28304473 | ||
| Control of Effector CD8 + T Cell Function by the Transcription Factor Eomesodermin | Q28589387 | ||
| Multiple sclerosis: T-cell receptor expression in distinct brain regions | Q33300045 | ||
| The genetics and epigenetics of autoimmune diseases | Q33642586 | ||
| Metabolic control of the epigenome in systemic Lupus erythematosus | Q33664849 | ||
| Oxidative stress in the pathology and treatment of systemic lupus erythematosus | Q33715508 | ||
| HRES-1/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLE. | Q33717763 | ||
| Immune regulation of multiple sclerosis by CD8+ T cells | Q34017004 | ||
| Oxidative stress, T cell DNA methylation, and lupus | Q34077487 | ||
| Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation | Q34117812 | ||
| Altered miRNA expression in T regulatory cells in course of multiple sclerosis | Q34126437 | ||
| Promoter-specific activation and demethylation by MBD2/demethylase | Q34144453 | ||
| MicroRNA-29b modulates innate and antigen-specific immune responses in mouse models of autoimmunity | Q34155591 | ||
| CD8+ Treg cells suppress CD8+ T cell-responses by IL-10-dependent mechanism during H5N1 influenza virus infection. | Q34193058 | ||
| Generalized Lévy walks and the role of chemokines in migration of effector CD8+ T cells | Q34283399 | ||
| Clinical implications of shared genetics and pathogenesis in autoimmune diseases | Q34365119 | ||
| Methionine metabolism in mammals | Q34366989 | ||
| Diagnosis and classification of Graves' disease | Q34397821 | ||
| Mechanistic target of rapamycin complex 1 expands Th17 and IL-4+ CD4-CD8- double-negative T cells and contracts regulatory T cells in systemic lupus erythematosus | Q34412837 | ||
| Disruption of CD8+ Treg activity results in expansion of T follicular helper cells and enhanced antitumor immunity. | Q34441115 | ||
| Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin | Q34465675 | ||
| CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer | Q34585720 | ||
| Rapamycin-sensitive signals control TCR/CD28-driven Ifng, Il4 and Foxp3 transcription and promoter region methylation | Q34628368 | ||
| Lymphocyte-platelet crosstalk in Graves' disease | Q34661055 | ||
| The interface between transcriptional and epigenetic control of effector and memory CD8⁺ T-cell differentiation | Q34712267 | ||
| Cytokines and the inception of CD8 T cell responses | Q34783475 | ||
| Histone acetylation facilitates rapid and robust memory CD8 T cell response through differential expression of effector molecules (eomesodermin and its targets: perforin and granzyme B). | Q34784615 | ||
| A central role for mTOR kinase in homeostatic proliferation induced CD8+ T cell memory and tumor immunity | Q34876814 | ||
| The epigenetics of autoimmunity | Q34979322 | ||
| Treg cells require the phosphatase PTEN to restrain TH1 and TFH cell responses. | Q34979730 | ||
| Mammalian sirtuins and energy metabolism | Q35005409 | ||
| HDAC inhibition in lupus models | Q35016981 | ||
| MicroRNA-34a enhances T cell activation by targeting diacylglycerol kinase ζ. | Q35023511 | ||
| Epigenetic Alterations in Cellular Immunity: New Insights into Autoimmune Diseases | Q39142245 | ||
| Mechanisms and Dynamics of T Cell-Mediated Cytotoxicity In Vivo. | Q39302905 | ||
| miR-625-3p is upregulated in CD8+ T cells during early immune reconstitution after allogeneic stem cell transplantation | Q40064947 | ||
| Differential gene induction by type I and type II interferons and their combination | Q40262695 | ||
| Identification of the IFITM family as a new molecular marker in human colorectal tumors | Q40314375 | ||
| Rapid alteration of microRNA levels by histone deacetylase inhibition | Q40322140 | ||
| Early transcriptional and epigenetic regulation of CD8+ T cell differentiation revealed by single-cell RNA sequencing. | Q40325436 | ||
| The Chemokine Receptor CX3CR1 Defines Three Antigen-Experienced CD8 T Cell Subsets with Distinct Roles in Immune Surveillance and Homeostasis | Q40414812 | ||
| Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients | Q40656580 | ||
| Central Nervous System Stromal Cells Control Local CD8(+) T Cell Responses during Virus-Induced Neuroinflammation | Q40775503 | ||
| Infantile seborrheic dermatitis. Morphological and immunopathological study | Q41353545 | ||
| Granzyme B promotes cytotoxic lymphocyte transmigration via basement membrane remodeling. | Q41590208 | ||
| Autologous hematopoietic SCT normalizes miR-16, -155 and -142-3p expression in multiple sclerosis patients | Q41715953 | ||
| IFNgamma-producing, virus-specific CD8+ effector cells acquire the ability to produce IL-10 as a result of entry into the infected lung environment | Q41845687 | ||
| Methylation status of CpG islands flanking a cAMP response element motif on the protein phosphatase 2Ac alpha promoter determines CREB binding and activity | Q41959555 | ||
| Global DNA methylation remodeling accompanies CD8 T cell effector function. | Q42275830 | ||
| The effects of CD40- and interleukin (IL-4)-activated CD23+ cells on the production of IL-10 by mononuclear cells in Graves' disease: the role of CD8+ cells | Q42520842 | ||
| IFI44L promoter methylation as a blood biomarker for systemic lupus erythematosus | Q42625867 | ||
| DNA hypomethylation of inflammation-associated genes in adipose tissue of female mice after multigenerational high fat diet feeding | Q44026024 | ||
| Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus | Q44062277 | ||
| Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus | Q45217503 | ||
| Physical and functional interactions between the human DNMT3L protein and members of the de novo methyltransferase family. | Q45956433 | ||
| Epigenetics and microRNAs | Q46057707 | ||
| Accelerated macrophage apoptosis induces autoantibody formation and organ damage in systemic lupus erythematosus | Q46925835 | ||
| Review: Metabolic Control of Immune System Activation in Rheumatic Diseases | Q47133379 | ||
| Genome-wide DNA methylation analysis in systemic sclerosis reveals hypomethylation of interferon-associated genes in CD4+ and CD8+ T cells | Q47178838 | ||
| MicroRNA-140 suppresses osteosarcoma tumor growth by enhancing anti-tumor immune response and blocking mTOR signaling | Q47369820 | ||
| Survival of autoreactive T lymphocytes by microRNA-mediated regulation of apoptosis through TRAIL and Fas in type 1 diabetes. | Q47611305 | ||
| The impact of cellular metabolism on chromatin dynamics and epigenetics | Q47617054 | ||
| Cutting edge: TCR stimulation is sufficient for induction of Foxp3 expression in the absence of DNA methyltransferase 1. | Q47765824 | ||
| Demethylation of promoter regulatory elements contributes to perforin overexpression in CD4+ lupus T cells | Q47991791 | ||
| Epigenetic Networks Regulate the Transcriptional Program in Memory and Terminally Differentiated CD8+ T Cells. | Q48154175 | ||
| Activated CD8+ T cell extracellular vesicles prevent tumour progression by targeting of lesional mesenchymal cells. | Q49246137 | ||
| microRNA expressions in CD4+ and CD8+ T-cell subsets in autoimmune thyroid diseases. | Q50460948 | ||
| Histone deacetylase (HDAC) inhibitor ACY241 enhances anti-tumor activities of antigen-specific central memory cytotoxic T lymphocytes against multiple myeloma and solid tumors. | Q50533942 | ||
| CRYAB modulates the activation of CD4+ T cells from relapsing-remitting multiple sclerosis patients. | Q50937116 | ||
| Abnormal histone acetylation of CD8+ T cells in patients with severe aplastic anemia. | Q51598382 | ||
| Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients. | Q51799957 | ||
| Differentiation of human CD8(+) T cells from a memory to memory/effector phenotype. | Q52012681 | ||
| Rapid demethylation of the IFN-gamma gene occurs in memory but not naive CD8 T cells. | Q52022962 | ||
| Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial. | Q52650139 | ||
| CD8 T cells and mTOR: new concepts and targets for systemic lupus erythematosus. | Q52650140 | ||
| CD8+HLA-DR+ T cells are increased in patients with severe aplastic anemia. | Q54200652 | ||
| Abnormalities of quantities and functions of linker for activations of T cells in severe aplastic anemia. | Q54364478 | ||
| Cooperative Instruction of Signaling and Metabolic Pathways on the Epigenetic Landscape. | Q54944228 | ||
| Early Everolimus Initiation Fails to Counteract the Cytotoxic Response Mediated by CD8 T and NK Cells in Heart Transplant Patients | Q57491427 | ||
| Metabolic Signaling into Chromatin Modifications in the Regulation of Gene Expression | Q60950072 | ||
| Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis | Q62748342 | ||
| S-Adenosylmethionine and S-adenosylhomocystein metabolism in isolated rat liver. Effects of L-methionine, L-homocystein, and adenosine | Q71364484 | ||
| Evidence of a combined cytotoxic thyroglobulin and thyroperoxidase epitope-specific cellular immunity in Hashimoto's thyroiditis | Q83280554 | ||
| CpG island methylation pattern in different human tissues and its correlation with gene expression | Q83642628 | ||
| CD8+ T cells in systemic sclerosis | Q84474506 | ||
| Advances on CD8+ Treg Cells and Their Potential in Transplantation | Q88456088 | ||
| Metabolism as a Target for Modulation in Autoimmune Diseases | Q88607770 | ||
| Crosstalk between metabolism and epigenetic modifications in autoimmune diseases: a comprehensive overview | Q89424601 | ||
| Methylation-Demethylation Dynamics: Implications of Changes in Acute Kidney Injury | Q90727203 | ||
| Generating long-lived CD8(+) T-cell memory: Insights from epigenetic programs. | Q37280990 | ||
| Metabolism and epigenetics. | Q37388258 | ||
| Genetic disruption of CD8+ Treg activity enhances the immune response to viral infection | Q37421220 | ||
| Epigenetic therapeutics in autoimmune disease | Q37567572 | ||
| Epigenetic histone code and autoimmunity | Q37575071 | ||
| Pathogenic CD8(+) T cells in multiple sclerosis | Q37594690 | ||
| Epigenetics and autoimmunity | Q37669513 | ||
| Dysregulated miR34a/diacylglycerol kinase ζ interaction enhances T-cell activation in acquired aplastic anemia | Q37701557 | ||
| Diabetes mellitus, a microRNA-related disease? | Q37855088 | ||
| Epigenetics and autoimmunity, with special emphasis on methylation | Q37860845 | ||
| CD8(+) T cells: foot soldiers of the immune system | Q37922333 | ||
| FOXP3+ regulatory T cells: from suppression of rejection to induction of renal allograft tolerance | Q37937127 | ||
| Etiology of autoimmune disease: past, present and future | Q37979837 | ||
| Potential roles for CD8(+) T cells in rheumatoid arthritis. | Q38030281 | ||
| Epigenetics in autoimmune diseases with focus on type 1 diabetes | Q38062497 | ||
| The critical importance of epigenetics in autoimmunity | Q38078660 | ||
| Promotion and prevention of autoimmune disease by CD8+ T cells | Q38122896 | ||
| Calorie restriction and NAD⁺/sirtuin counteract the hallmarks of aging | Q38217569 | ||
| Acetyl-CoA induces cell growth and proliferation by promoting the acetylation of histones at growth genes. | Q35027765 | ||
| The role of T-cells in the pathogenesis of Type 1 diabetes: from cause to cure | Q35103993 | ||
| miR-29a and miR-29b contribute to pancreatic beta-cell-specific silencing of monocarboxylate transporter 1 (Mct1) | Q35139405 | ||
| Genome-wide DNA methylation profiles indicate CD8+ T cell hypermethylation in multiple sclerosis | Q35143918 | ||
| Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice | Q35486021 | ||
| Epigenetic control of interferon-gamma expression in CD8 T cells. | Q35564148 | ||
| Methylation and demethylation in the regulation of genes, cells, and responses in the immune system | Q35571270 | ||
| Epigenetic mechanisms in systemic lupus erythematosus and other autoimmune diseases | Q35577576 | ||
| SIRT1-Mediated eNAMPT Secretion from Adipose Tissue Regulates Hypothalamic NAD+ and Function in Mice | Q35588961 | ||
| Hepatitis B virus X protein induces EpCAM expression via active DNA demethylation directed by RelA in complex with EZH2 and TET2. | Q35609669 | ||
| Oxidative stress and Treg depletion in lupus patients with anti-phospholipid syndrome | Q35732790 | ||
| The role of epigenetic variation in the pathogenesis of systemic lupus erythematosus | Q35840786 | ||
| Epigenetics and autoimmune diseases. | Q35867015 | ||
| Initial T cell receptor transgenic cell precursor frequency dictates critical aspects of the CD8(+) T cell response to infection. | Q36008100 | ||
| Analysis of CD8+ Treg cells in patients with ovarian cancer: a possible mechanism for immune impairment | Q36085104 | ||
| Histone Methylation Dynamics and Gene Regulation Occur through the Sensing of One-Carbon Metabolism | Q36253836 | ||
| Genome-wide DNA methylation profiling of CD8+ T cells shows a distinct epigenetic signature to CD4+ T cells in multiple sclerosis patients | Q36255464 | ||
| Autoimmune disease in the epigenetic era: how has epigenetics changed our understanding of disease and how can we expect the field to evolve? | Q36257320 | ||
| Scleroderma: from cell and molecular mechanisms to disease models | Q36259889 | ||
| miR-150 Regulates Differentiation and Cytolytic Effector Function in CD8+ T cells | Q36262472 | ||
| Cytotoxic T lymphocytes and autoimmunity | Q36285811 | ||
| CD8+ T cells in autoimmunity | Q36286977 | ||
| MicroRNAs and Their Targets Are Differentially Regulated in Adult and Neonatal Mouse CD8+ T Cells | Q36291335 | ||
| The molecular basis of the memory T cell response: differential gene expression and its epigenetic regulation | Q36390497 | ||
| Lupus autoimmunity altered by cellular methylation metabolism | Q36527588 | ||
| Inflaming the CD8+ T cell response. | Q36543883 | ||
| The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine | Q36731236 | ||
| Interplay between Metabolism and Epigenetics: A Nuclear Adaptation to Environmental Changes | Q36969070 | ||
| miR-142-3p restricts cAMP production in CD4+CD25- T cells and CD4+CD25+ TREG cells by targeting AC9 mRNA. | Q37087212 | ||
| An endogenous positively selecting peptide enhances mature T cell responses and becomes an autoantigen in the absence of microRNA miR-181a | Q37145975 | ||
| microRNAs and the immune response | Q37178538 | ||
| Autoimmune mechanisms in type 1 diabetes | Q37215820 | ||
| MicroRNAs: new regulators of immune cell development and function | Q37223449 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systematic review | Q1504425 |
| histone modification | Q14911658 | ||
| Mirnas | Q16464788 | ||
| P304 | page(s) | 856 | |
| P577 | publication date | 2019-01-01 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | The Emerging Epigenetic Role of CD8+T Cells in Autoimmune Diseases: A Systematic Review | |
| P478 | volume | 10 |
| Q96304897 | The contribution of epigenetics to the pathogenesis and gender dimorphism of systemic sclerosis: a comprehensive overview |
| Q98567727 | Transcription and DNA Methylation patterns of blood derived CD8+ T cells are associated with age and Inflammatory Bowel Disease but do not predict prognosis |
| Q92309432 | Transcriptome Analysis and Emerging Driver Identification of CD8+ T Cells in Patients with Vitiligo |
Search more.